...
首页> 外文期刊>Medicine. >Symptomatic Peripheral Mycotic Aneurysms Due to Infective Endocarditis: A Contemporary Profile
【24h】

Symptomatic Peripheral Mycotic Aneurysms Due to Infective Endocarditis: A Contemporary Profile

机译:感染性心内膜炎导致的症状性周围性真菌性动脉瘤的当代特征

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Abstract: Peripheral mycotic aneurysms (PMAs) are a relatively rare but serious complication of infective endocarditis (IE). We conducted the current study to describe and compare the current epidemiologic, microbiologic, clinical, diagnostic, therapeutic, and prognostic characteristics of patients with symptomatic PMAs (SPMAs). A descriptive, comparative, retrospective observational study was performed in 3 tertiary hospitals, which are reference centers for cardiac surgery. From 922 definite IE episodes collected from 1996 to 2011, 18 patients (1.9%) had SPMAs. Because all SPMAs developed in left-sided IE, we performed a comparative study between 719 episodes of left-sided IE without SPMAs and 18 episodes with SPMAs. We found a higher frequency of intravenous drug abuse, native valve IE, intracranial bleeding, septic emboli, multiple embolisms, and IE diagnostic delay >30 days in patients with SPMAs than in patients without SPMAs. The causal microorganisms were gram-positive cocci (n =10), gram-negative bacilli (n = 2), gram-positive bacilli (n = 3), Bartonella henselae (n = 1), Candida albicans (n = 1), and negative culture (n = 1). The median IE diagnosis delay was 15 days (interquartile range [IQR], 13–33 d) in the case of high-virulence microorganisms versus 45 days (IQR, 30–240 d) in the case of low- to medium-virulence microorganisms. Twelve SPMAs were intracranial and 6 were extracranial. In 10 cases (8 intracranial and 2 extracranial), SPMAs were the initial presentation of IE; the remaining cases developed symptoms during or after finishing parenteral antibiotic treatment. The initial diagnosis of intracranial SPMAs was made by computed tomography (CT) or magnetic resonance imaging in 6 unruptured aneurysms and by angiography in 6 ruptured aneurysms. The initial test in extracranial SPMAs was Doppler ultrasonography in limbs, CT in liver, and coronary angiography in heart. Four (3 intracranial, 1 extracranial) of 7 (6 intracranial, 1 extracranial) patients treated only with antibiotics died. Surgical resection was performed in 7 (3 intracranial, 4 extracranial) and endovascular repair in 4 (3 intracranial, 1 extracranial) patients; all of them survived. In conclusion, we found that SPMAs were a rare complication of IE that developed only in left-sided IE, and especially in native valves. Intracranial hemorrhage, embolism, multiple embolisms, and diagnostic delay of IE were more common in patients with SPMAs. The microbiologic profile was diverse, but microorganisms of low-medium virulence were predominant, and had a greater delayed diagnosis of IE than those caused by microorganisms of high virulence. SPMAs were often the initial presentation of IE. The most common location of SPMAs was intracranial. Noninvasive radiologic imaging techniques were the initial imaging test in intracranial unruptured SPMAs and in most extracranial SPMAs. Surgical and endovascular treatments were safe and effective. Endovascular treatment could be the first line of treatment in selected cases. Mortality was high in those cases treated only with antibiotics.
机译:摘要:周围性霉菌性动脉瘤(PMA)是一种相对罕见但严重的感染性心内膜炎(IE)并发症。我们进行了当前研究,以描述和比较有症状PMA(SPMA)患者的当前流行病学,微生物学,临床,诊断,治疗和预后特征。在三家三级医院进行了描述性,比较性,回顾性观察性研究,它们是心脏外科手术的参考中心。从1996年至2011年收集的922次明确的IE发作中,有18位患者(1.9%)患有SPMA。因为所有SPMA都是在左侧IE中开发的,所以我们对719次不带SPMA的左侧IE和18个SPMA进行了比较研究。我们发现SPMA患者的静脉药物滥用,天然瓣膜IE,颅内出血,败血性栓塞,多发性栓塞和IE诊断延迟> 30天的频率高于无SPMA的患者。病原微生物是革兰氏阳性球菌(n = 10),革兰氏阴性杆菌(n = 2),革兰氏阳性杆菌(n = 3),半月形小孢子菌(n = 1),白色念珠菌(n = 1),和负面文化(n = 1)。对于高毒力微生物,IE诊断中位延迟为15天(四分位间距[IQR],13-33 d),而对于中低毒力微生物,IE诊断延迟为45天(IQR,30-240 d) 。十二枚SPMA位于颅内,六枚位于颅外。在10例(颅内8例,颅外2例)中,SPMAs是IE的最初表现。其余病例在非肠道抗生素治疗期间或之后出现症状。颅内SPMA的初步诊断是通过计算机断层扫描(CT)或磁共振成像检查6例未破裂动脉瘤,以及通过血管造影术检查6例破裂动脉瘤。颅外SPMA的最初测试是四肢多普勒超声检查,肝脏CT检查以及心脏冠状动脉造影检查。仅用抗生素治疗的7例患者(4例颅内,1例颅外)中有4例(3例颅内,1例颅外)死亡。 7例(颅内3例,颅外4例)手术切除,4例(颅内3例,颅外1例)血管内修复。他们全部幸存下来。总之,我们发现SPMA是IE的罕见并发症,仅在左侧IE中特别是在天然瓣膜中发展。在SPMA患者中,颅内出血,栓塞,多发栓塞和IE诊断延迟更为常见。微生物谱是多种多样的,但是中低毒力的微生物占主导地位,并且与高毒力的微生物相比,IE的延迟诊断更大。 SPMA通常是IE的最初表示。 SPMA最常见的位置是颅内。无创放射成像技术是颅内未破裂的SPMA和大多数颅外SPMA的初始成像测试。手术和血管内治疗是安全有效的。在某些情况下,血管内治疗可能是治疗的第一线。在仅使用抗生素治疗的情况下,死亡率很高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号